Recombinant Vibrio vulnificus Arginine repressor (argR)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and pre-arranged. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to ensure contents settle. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
argR; VV0466Arginine repressor
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-156
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
argR
Target Protein Sequence
MRPSEKQDNL VRAFKALLKE ERFGSQGEIV EALKQEGFEN INQSKVSRML TKFGAVRTRN AKMEMVYCLP TELGVPTVSS SLRELVLDVD HNQALVVIHT GPGAAQLIAR MLDSLGKSEG ILGVVAGDDT IFITPTLTIT TEQLFKSVCE LFEYAG
Uniprot No.

Target Background

Function
Regulates arginine biosynthesis genes.
Database Links

KEGG: vvy:VV0466

Protein Families
ArgR family
Subcellular Location
Cytoplasm.

Q&A

What is the basic structure and function of Vibrio vulnificus ArgR?

Vibrio vulnificus ArgR is a transcriptional regulator that belongs to the ArgR/AhrC family of transcriptional regulators. Like other bacterial ArgR proteins, it likely functions as a hexameric protein complex that requires allosteric activation by L-arginine to bind to specific DNA sequences called ARG boxes near target promoters. The protein typically contains a DNA-binding domain at the N-terminus and an oligomerization/arginine-binding domain at the C-terminus. Based on studies in related Vibrio species, V. vulnificus ArgR likely acts as a transcriptional activator of the arginine deiminase (ADI) pathway, which plays an important role in bacterial environmental adaptation and pathogenicity .

How does the ArgR protein respond to different concentrations of L-arginine?

The ArgR protein functions as an arginine-dependent regulatory protein that requires allosteric activation by L-arginine. At sufficient L-arginine concentrations, ArgR forms a hexamer that can bind to specific operator sequences (ARG boxes) in the promoter regions of target genes. The binding affinity of ArgR to its target sequences is directly proportional to the concentration of L-arginine available as a corepressor. This concentration-dependent response allows the bacterium to modulate gene expression based on arginine availability . In related species, this binding can either repress or activate transcription depending on the specific target gene, with the ArgR-regulated pathways becoming progressively more active as arginine concentrations increase .

What are the primary target genes regulated by ArgR in Vibrio vulnificus?

Based on studies in related Vibrio species such as V. fluvialis, the primary targets of ArgR regulation likely include the ADI pathway gene cluster, which typically consists of two operons: arcD and arcACB. These genes encode proteins involved in arginine utilization: arginine deiminase (ArcA), ornithine carbamoyltransferase (ArcB), carbamate kinase (ArcC), and an arginine-ornithine antiporter (ArcD) . In other bacteria, ArgR also regulates genes encoding arginine transporters (glnPQ, artJ) that allow bacteria to import arginine from extracellular sources . The specific binding sites for V. vulnificus ArgR would be expected to contain ARG box sequences in the promoter regions of these target genes.

What are the most effective methods for cloning and expressing recombinant V. vulnificus ArgR?

For effective cloning and expression of recombinant V. vulnificus ArgR, researchers should consider the following methodology:

  • Gene amplification: Use PCR to amplify the argR gene from V. vulnificus genomic DNA using high-fidelity DNA polymerase such as Tgo DNA polymerase.

  • Cloning vector selection: The expression vector pRSET-C (or similar) can be used to create a construct that expresses full-length ArgR with an N-terminal six-histidine tag for easy purification.

  • Primer design: Design primers that include appropriate restriction sites (such as KpnI) to facilitate directional cloning.

  • Verification: Sequence the resulting plasmid to ensure that the coding region matches the published sequence without mutations.

  • Expression conditions: Express in E. coli BL21(DE3) or similar strain under IPTG induction, with optimization of temperature and induction time to maximize soluble protein production.

This approach is similar to methods that have been successfully employed for expression of ArgR from other bacterial species .

What techniques are most reliable for studying ArgR-DNA interactions?

Several complementary techniques provide reliable data for studying ArgR-DNA interactions:

  • Electrophoretic Mobility Shift Assay (EMSA): This technique can demonstrate specific binding of purified recombinant ArgR to predicted ARG box sequences in promoter regions of target genes. The assay should be performed with varying concentrations of L-arginine to demonstrate the corepressor dependency of binding.

  • DNase I footprinting: This method precisely identifies the DNA sequences protected by ArgR binding, allowing for accurate mapping of ARG boxes within promoter regions.

  • Point mutation analysis: Introducing specific mutations in predicted ARG boxes followed by binding assays can confirm the importance of specific nucleotides for ArgR recognition.

  • Reporter gene fusion assays: Constructing fusion reporters (such as luxCDABE) driven by promoters containing ARG boxes can demonstrate ArgR-mediated regulation in vivo.

These techniques have been successfully applied in studies of ArgR regulation in related species and would be applicable to V. vulnificus ArgR research.

How can researchers effectively measure the impact of ArgR on gene expression in V. vulnificus?

To effectively measure ArgR's impact on gene expression:

  • Quantitative RT-PCR: Compare mRNA levels of predicted target genes between wild-type and ΔargR mutant strains under various growth conditions, particularly with different arginine concentrations. This approach can reveal significant differences in expression levels, as demonstrated in V. fluvialis where arcD expression showed substantial reduction in the ΔargR strain .

  • Reporter gene fusion assays: Construct promoter-reporter fusions (using luxCDABE, lacZ, or GFP) to monitor promoter activity in real-time under different conditions and in different genetic backgrounds.

  • RNA-seq: Perform comparative transcriptome analysis between wild-type and ΔargR mutant strains to identify the complete ArgR regulon, including potentially unexpected target genes.

  • Chromatin Immunoprecipitation (ChIP): This technique can identify genome-wide binding sites of ArgR in vivo, offering insights into the complete regulatory network.

  • In vitro transcription assays: These can demonstrate direct effects of purified ArgR on transcription from specific promoters in a controlled environment.

How does the ArgR-regulated ADI pathway contribute to acid resistance in V. vulnificus?

The ArgR-regulated ADI pathway likely contributes significantly to acid resistance in V. vulnificus through a mechanism similar to that observed in V. fluvialis:

The ADI pathway catalyzes the conversion of arginine to ornithine, ammonia, and CO₂, with the production of ATP. The ammonia generated can neutralize protons, thereby increasing the intracellular pH and the pH of the surrounding environment. In V. fluvialis, this pathway has been demonstrated to enhance bacterial survival in acidic environments both in vitro and in vivo .

The process involves:

  • Uptake of arginine through the ArcD transporter

  • Conversion of arginine to citrulline by arginine deiminase (ArcA), releasing ammonia

  • Conversion of citrulline to ornithine and carbamoyl phosphate by ornithine carbamoyltransferase (ArcB)

  • Conversion of carbamoyl phosphate to CO₂ and ammonia with ATP production by carbamate kinase (ArcC)

  • Export of ornithine in exchange for arginine via ArcD

This system allows V. vulnificus to neutralize acidic environments, which is crucial for survival in host environments such as the stomach and within phagolysosomes of immune cells .

What is the relationship between ArgR regulation and virulence factor expression in V. vulnificus?

The relationship between ArgR regulation and virulence factor expression in V. vulnificus likely involves several interconnected pathways:

  • Acid resistance: The ArgR-regulated ADI pathway enhances survival in acidic environments, which is essential for successful colonization and invasion of the host. This represents an indirect contribution to virulence.

  • Potential cross-regulation with hemolytic toxins: In V. vulnificus, the expression of the hemolysin gene (vvhA) is regulated by complex systems including HlyU, a master virulence factor transcriptional regulator . While direct ArgR regulation of vvhA hasn't been established, regulatory overlap between metabolic and virulence systems is common in pathogenic bacteria.

  • Nutrient acquisition: ArgR-regulated systems for arginine uptake and metabolism may enhance bacterial fitness during infection by providing essential nutrients and energy.

  • Host immune evasion: The ADI pathway may contribute to immune evasion by depleting arginine, which is necessary for nitric oxide production by host macrophages.

Further research is needed to fully elucidate the direct connections between ArgR regulation and specific virulence factors in V. vulnificus.

How do environmental conditions affect ArgR activity and its regulatory network?

Environmental conditions significantly influence ArgR activity and its regulatory network through multiple mechanisms:

  • Arginine availability: The primary environmental factor affecting ArgR activity is L-arginine concentration. ArgR requires L-arginine as a corepressor for effective DNA binding and regulatory function . Changes in environmental arginine levels directly impact the formation of active ArgR hexamers.

  • pH: Acidic conditions likely enhance the importance of the ArgR-regulated ADI pathway for bacterial survival. Studies in V. fluvialis have shown that expression of the ADI gene cluster is upregulated in acidic environments, with ArgR playing a crucial role in this response .

  • Oxygen levels: While not directly studied for V. vulnificus ArgR, anaerobic conditions often influence arginine metabolism in bacteria, potentially affecting ArgR regulatory activities.

  • Temperature: As a pathogen that can transition between environmental and host settings, V. vulnificus experiences temperature fluctuations that may affect ArgR activity, possibly through changes in protein conformation or stability.

  • Growth phase: The ArgR regulatory network may respond differently during various bacterial growth phases, reflecting changing metabolic needs.

Understanding these environmental influences is crucial for interpreting experimental results and designing studies that accurately reflect physiologically relevant conditions.

How does V. vulnificus ArgR differ from ArgR in other Vibrio species and model organisms?

Comparison of V. vulnificus ArgR with those from other bacterial species reveals important similarities and differences:

SpeciesFunctionTarget GenesDistinctive Features
V. vulnificusLikely transcriptional activatorPredicted: ADI pathway (arcD, arcACB)Role in acid resistance and pathogenesis
V. fluvialisTranscriptional activatorADI gene cluster (arcD, arcACB operons)Enhances survival in acidic environments
C. pneumoniaeArginine-dependent aporepressorArginine transport system (glnPQ, artJ)Represses transcription of glnPQ
E. coliTranscriptional repressorArginine biosynthesis genesWell-characterized model system

The primary differences likely include:

  • DNA binding specificity: The specific ARG box sequences recognized may differ.

  • Regulatory outcome: While some ArgR proteins function primarily as repressors (as in C. pneumoniae ), others act as activators (as in V. fluvialis ).

  • Regulon composition: The suite of genes regulated by ArgR varies among species, reflecting different metabolic needs and environmental adaptations.

These differences reflect evolutionary adaptations to specific ecological niches and metabolic requirements.

What conservation exists in ArgR binding sites across different Vibrio species?

ArgR binding sites (ARG boxes) show significant conservation across different Vibrio species, while also displaying species-specific adaptations:

  • Core consensus sequence: ARG boxes typically consist of an 18-bp palindromic sequence that is recognized by the ArgR hexamer. The core consensus is likely preserved across Vibrio species.

  • Arrangement patterns: In V. fluvialis, multiple potential ArgR binding sites have been identified at the arcD and arcACB promoter regions . Similar arrangements might exist in V. vulnificus.

  • Species-specific variations: Despite conservation of the core binding motif, species-specific variations in ARG box sequences likely exist, as observed between C. pneumoniae and C. trachomatis, where C. pneumoniae ArgR could bind ARG boxes for C. caviae glnPQ but not C. trachomatis glnPQ .

  • Tandem arrangements: In some cases, ARG boxes are arranged in tandem, which may enhance regulatory control through cooperative binding.

  • Positional conservation: ARG boxes are typically located near promoters of regulated genes, with their exact position determining whether ArgR acts as a repressor or activator.

Bioinformatic analyses using position weight matrices derived from known ARG boxes can be used to predict potential binding sites in V. vulnificus.

How does the organization of the ADI gene cluster in V. vulnificus compare to other Vibrio species?

The organization of the ADI gene cluster shows both conservation and variation across Vibrio species:

This organization reflects the evolutionary history and metabolic specialization of different Vibrio species.

How does the ArgR-regulated ADI pathway contribute to V. vulnificus pathogenesis?

The ArgR-regulated ADI pathway likely contributes to V. vulnificus pathogenesis through several mechanisms:

  • Acid resistance: By metabolizing arginine to produce ammonia, the ADI pathway helps neutralize acidic environments, enabling survival during passage through the stomach and within phagolysosomes of immune cells. This enhances the bacterium's ability to establish infection and disseminate within the host .

  • Energy production: The ADI pathway generates ATP, providing an energy advantage during infection when other metabolic pathways may be restricted.

  • Immune modulation: By depleting arginine in the microenvironment, the ADI pathway may impair host immune functions that require arginine, such as nitric oxide production by macrophages.

  • Biofilm formation: In some bacteria, the ADI pathway influences biofilm formation, which contributes to persistence and antibiotic resistance.

  • Virulence factor regulation: The ADI pathway may interact with regulatory networks controlling other virulence factors. In V. vulnificus, virulence factors like hemolysin (VVH) contribute to pathogenesis by causing cytotoxicity, vascular damage, and inflammatory responses .

Understanding these contributions is essential for developing strategies to target V. vulnificus infections.

What role might ArgR play in V. vulnificus survival within macrophages?

ArgR likely plays a significant role in V. vulnificus survival within macrophages through several mechanisms:

  • Acid resistance: Phagolysosomes within macrophages present an acidic environment. The ArgR-regulated ADI pathway produces ammonia that can neutralize this acidity, enhancing bacterial survival. Studies in V. fluvialis have demonstrated that the ADI pathway significantly enhances survival in macrophages .

  • Arginine competition: Macrophages require arginine for the production of nitric oxide (NO), a key antimicrobial molecule. The ArgR-regulated ADI pathway depletes available arginine, potentially limiting NO production and improving bacterial survival.

  • Energy production: The ATP generated by the ADI pathway provides energy for bacterial survival under the stressful conditions within macrophages.

  • Inflammatory response modulation: V. vulnificus interactions with macrophages trigger inflammatory responses. VVH has been shown to induce NLRP3 inflammasome activation in macrophages , and the ArgR-regulated system may interact with these pathways to modify host responses.

  • Resistance to oxidative stress: Macrophages produce reactive oxygen species to kill bacteria. The ArgR regulatory network might include genes involved in oxidative stress resistance.

These mechanisms collectively enhance V. vulnificus persistence within host immune cells.

Can ArgR regulation be targeted for therapeutic intervention against V. vulnificus infections?

Targeting ArgR regulation presents several promising approaches for therapeutic intervention against V. vulnificus infections:

  • Inhibition of ArgR function: Small molecules that interfere with ArgR binding to DNA or with L-arginine binding to ArgR could disrupt the regulatory network, potentially reducing bacterial survival under stress conditions.

  • ADI pathway inhibition: Developing inhibitors against key enzymes in the ADI pathway (ArcA, ArcB, ArcC) could reduce bacterial acid resistance and survival.

  • Targeting global regulators: An approach similar to that used for inhibiting HlyU (a master virulence factor regulator in V. vulnificus) could be applied. For example, fursultiamine hydrochloride was identified as an inhibitor of HlyU-regulated virulence genes , and similar screening could identify inhibitors of ArgR-regulated genes.

  • Arginine supplementation therapy: Providing excess arginine could potentially overwhelm the bacterial ADI system and ensure sufficient arginine for host immune functions.

  • Combination approaches: Targeting ArgR regulation alongside conventional antibiotics might enhance treatment efficacy, particularly for antibiotic-resistant strains.

  • Vaccine development: ArgR-regulated proteins, particularly those exposed on the bacterial surface, might serve as vaccine candidates.

These approaches require further research to determine efficacy and safety, but represent promising directions for therapeutic development.

What are the main technical challenges in purifying functional recombinant V. vulnificus ArgR?

Researchers face several technical challenges when purifying functional recombinant V. vulnificus ArgR:

  • Protein solubility: ArgR proteins can form inclusion bodies when overexpressed in E. coli. Solutions include:

    • Optimizing expression conditions (temperature, induction time, inducer concentration)

    • Using solubility-enhancing fusion tags (MBP, SUMO, TrxA)

    • Co-expression with chaperones

    • Expressing in alternative host systems

  • Maintaining native conformation: The functional ArgR is a hexamer that requires L-arginine for proper assembly. Purification strategies should:

    • Include L-arginine in purification buffers

    • Use gentle purification conditions to preserve oligomeric state

    • Verify oligomerization status by size exclusion chromatography

  • DNA contamination: ArgR binds DNA, which can co-purify with the protein. This can be addressed by:

    • Including high salt washes in purification protocols

    • Treating samples with nucleases

    • Using ion exchange chromatography to separate DNA-bound and free forms

  • Stability during storage: Purified ArgR may lose activity during storage. Recommendations include:

    • Testing different buffer compositions

    • Adding stabilizing agents (glycerol, arginine, reducing agents)

    • Determining optimal storage temperature

    • Considering lyophilization for long-term storage

Addressing these challenges requires systematic optimization of expression and purification protocols.

How can researchers effectively generate and confirm argR knockout mutants in V. vulnificus?

Generating and confirming argR knockout mutants in V. vulnificus involves several critical steps:

  • Mutant construction strategies:

    • Allelic exchange: Create a construct with upstream and downstream regions of argR flanking an antibiotic resistance marker. This approach allows for clean deletion without polar effects on adjacent genes.

    • CRISPR-Cas9 system: Design guide RNAs targeting argR and provide a repair template to introduce the deletion or disruption.

    • Transposon mutagenesis: Screen transposon libraries for insertions in argR, though this is less targeted.

  • Selection and screening:

    • Use appropriate antibiotics for initial selection

    • Screen colonies by PCR to identify potential mutants

    • Verify the absence of argR by RT-PCR and Western blotting

  • Confirmation methods:

    • Whole genome sequencing to confirm the deletion and check for off-target mutations

    • Complementation studies: Reintroducing functional argR should restore the wild-type phenotype

    • Phenotypic assays: Compare growth in acidic conditions, as ΔargR mutants should show reduced survival

    • Gene expression analysis: Measure expression of ArgR target genes (e.g., arcD) using qRT-PCR or reporter assays

  • Controls to include:

    • Wild-type strain

    • Complemented mutant strain

    • Appropriate negative controls for all assays

These approaches ensure the generation of reliable mutants for studying ArgR function.

What are the best experimental designs to study the interaction between ArgR regulation and environmental stress responses?

Effective experimental designs to study ArgR regulation during environmental stress should:

  • Employ parallel comparative approaches:

    • Compare wild-type, ΔargR mutant, and complemented strains

    • Assess multiple stress conditions (acid, oxidative, temperature, nutrient limitation)

    • Use a time-course approach to capture dynamic responses

  • Utilize global profiling methods:

    • RNA-Seq to identify differentially expressed genes

    • ChIP-Seq to map ArgR binding sites under different conditions

    • Proteomics to identify changes in protein levels

    • Metabolomics to measure arginine and related metabolites

  • Develop controlled stress models:

    • In vitro acid stress models with defined pH levels

    • Macrophage infection models to study intracellular survival

    • Animal infection models to assess in vivo relevance

  • Use reporter systems:

    • Construct reporter fusions (luxCDABE, GFP) to monitor target gene expression

    • Design dual-reporter systems to simultaneously track multiple promoters

    • Develop real-time monitoring systems for continuous assessment

  • Apply synthetic biology approaches:

    • Create synthetic promoters with modified ARG boxes

    • Develop tunable ArgR expression systems

    • Engineer strains with altered arginine metabolism

These experimental designs provide comprehensive insights into how ArgR mediates adaptive responses to environmental stresses, particularly important for understanding V. vulnificus pathogenesis.

What emerging technologies could advance our understanding of ArgR function in V. vulnificus?

Several emerging technologies offer promising approaches to advance understanding of ArgR function:

  • Single-cell techniques:

    • Single-cell RNA-Seq to capture heterogeneity in ArgR-regulated gene expression

    • Time-lapse microscopy with fluorescent reporters to visualize dynamic responses

    • CyTOF or mass cytometry to analyze multiple parameters simultaneously

  • Advanced structural biology approaches:

    • Cryo-electron microscopy to visualize ArgR-DNA complexes at high resolution

    • Hydrogen-deuterium exchange mass spectrometry to map conformational changes

    • Integrative structural biology combining multiple techniques (X-ray crystallography, NMR, SAXS)

  • High-throughput screening methods:

    • CRISPR interference screens to identify genes that interact with ArgR

    • Synthetic genetic array analysis to map genetic interactions

    • Small molecule screens to identify ArgR inhibitors

  • Advanced genomics approaches:

    • ATAC-Seq to map changes in chromatin accessibility

    • Hi-C or ChIA-PET to analyze three-dimensional genome organization

    • Genome-wide CRISPR screens to identify new components of ArgR regulatory networks

  • Microfluidics and organ-on-chip:

    • Microfluidic devices to study bacterial responses to dynamic environmental changes

    • Organ-on-chip models to investigate host-pathogen interactions in a physiologically relevant context

These technologies will provide unprecedented insights into ArgR function at molecular, cellular, and systems levels.

How might comparative genomics inform our understanding of ArgR evolution and specialization in Vibrio species?

Comparative genomics approaches can significantly enhance our understanding of ArgR evolution:

  • Phylogenetic analysis:

    • Construct phylogenetic trees of ArgR proteins across Vibrio species and beyond

    • Compare evolutionary rates between DNA-binding and oligomerization domains

    • Identify signatures of positive selection that might indicate adaptation

  • Synteny analysis:

    • Examine conservation of gene order around argR and its target genes

    • Identify genomic rearrangements that might have influenced regulatory networks

    • Trace the history of horizontal gene transfer events involving argR or ADI pathway genes

  • Regulatory network comparisons:

    • Predict ARG boxes across multiple genomes to identify the core and variable regulons

    • Compare ARG box sequences to identify species-specific motif variations

    • Map regulatory network evolution by reconstructing ancestral states

  • Structure-function correlations:

    • Map sequence variations to structural models to identify functional innovations

    • Correlate amino acid changes with differences in DNA binding specificity or cooperativity

    • Identify co-evolving residues that maintain functional interactions

  • Ecological context integration:

    • Correlate genomic features with ecological niches and pathogenic potential

    • Identify genomic signatures associated with specific host adaptations

    • Link regulatory network structure to environmental adaptation strategies

These approaches would help explain why certain Vibrio species have complete ADI pathways while others, including some strains of V. vulnificus, may lack certain components , providing insights into the evolution of virulence and environmental adaptation.

What are the most promising directions for translating basic research on ArgR into clinical applications?

Translating basic research on V. vulnificus ArgR into clinical applications offers several promising directions:

  • Novel antimicrobial strategies:

    • Develop small molecule inhibitors targeting ArgR or ARG box interactions

    • Design peptide mimetics that disrupt ArgR oligomerization or DNA binding

    • Create CRISPR-based antimicrobials targeting argR or its regulatory sites

  • Diagnostic tools:

    • Develop rapid molecular diagnostics targeting ArgR-regulated genes

    • Create biosensors that detect ArgR activity as indicators of V. vulnificus virulence

    • Design point-of-care tests that distinguish virulent from avirulent strains

  • Vaccine development:

    • Evaluate ArgR-regulated surface antigens as vaccine candidates

    • Develop attenuated strains with modified ArgR regulation as live vaccines

    • Design subunit vaccines targeting multiple ArgR-regulated virulence factors

  • Host-directed therapies:

    • Develop strategies to modify host arginine metabolism to disadvantage bacteria

    • Target host-pathogen interfaces that involve ArgR-regulated processes

    • Design immunomodulatory approaches that enhance host resistance

  • Combination therapies:

    • Integrate ArgR-targeted approaches with conventional antibiotics

    • Develop anti-virulence therapies that don't create selective pressure for resistance

    • Create synergistic treatment regimens targeting multiple aspects of V. vulnificus pathogenesis

  • Predictive models:

    • Develop systems biology models that predict bacterial responses to treatment

    • Create patient stratification tools based on pathogen characteristics

    • Design decision support systems for clinicians treating V. vulnificus infections

These translational directions could lead to improved prevention, diagnosis, and treatment of V. vulnificus infections, which are associated with high mortality rates .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.